Projects per year
Personal profile
Headline
PROFESSOR | Microbiology PROFESSOR | Medicine, Infectious Diseases
Biography
Dr. Simon studies emerging pathogens. She has been awarded several grants from the National Institutes of Health for her investigations of HIV and has received several honors and awards for her work.
Fingerprint
Dive into the research topics where Viviana Simon is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Nasal RNA response to respiratory viral infections
Pan, T. T. & Simon, V.
National Institute of Allergy and Infectious Diseases
1/04/22 → 31/03/23
Project: Research
-
Defining the role of pseudouridine modifications in HIV biology
Simon, V. & Pan, T.
National Institute of Allergy and Infectious Diseases
1/08/19 → 31/07/20
Project: Research
-
Preventing CD4+ T memory cells from becoming HIV reservoirs
Simon, V. V. A. & Simon, V.
National Institute of Allergy and Infectious Diseases
18/05/18 → 30/04/22
Project: Research
-
Interplay between Negative Regulators of Type I Interferon and HIV control
National Institute of Allergy and Infectious Diseases
10/06/17 → 31/05/19
Project: Research
-
Targeting HIV persistence in CD4+ T memory stem cells
National Institute of Allergy and Infectious Diseases
10/08/16 → 31/07/17
Project: Research
-
Evaluation and validation of an RT-PCR assay for specific detection of monkeypox virus (MPXV)
Paniz-Mondolfi, A., Guerra, S., Muñoz, M., Luna, N., Hernandez, M. M., Patino, L. H., Reidy, J., Banu, R., Shrestha, P., Liggayu, B., Umeaku, A., Chen, F., Cao, L., Patel, A., Hanna, A., Li, S., Look, A., Pagani, N., Albrecht, R., Pearl, R., & 24 others, Jan 2023, In: Journal of Medical Virology. 95, 1, e28247.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron
PSP-PARIS Study Group, 24 Feb 2022, In: Nature. 602, 7898, p. 682-688 7 p.Research output: Contribution to journal › Article › peer-review
Open Access185 Scopus citations -
Antibodies targeting the neuraminidase active site inhibit influenza H3N2 viruses with an S245N glycosylation site
Stadlbauer, D., McMahon, M., Turner, H. L., Zhu, X., Wan, H., Carreño, J. M., O’Dell, G., Strohmeier, S., Khalil, Z., Luksza, M., van Bakel, H., Simon, V., Ellebedy, A. H., Wilson, I. A., Ward, A. B. & Krammer, F., Dec 2022, In: Nature Communications. 13, 1, 7864.Research output: Contribution to journal › Article › peer-review
Open Access -
A Robust, Highly Multiplexed Mass Spectrometry Assay to Identify SARS-CoV-2 Variants
Mount Sinai PSP Study Group, Sep 2022, In: Microbiology spectrum. 10, 5Research output: Contribution to journal › Article › peer-review
Open Access -
Augmentation of humoral and cellular immune responses after third-dose SARS-CoV-2 vaccination and viral neutralization in myeloma patients
PVI/MM/Seronet Study Group, 9 May 2022, In: Cancer Cell. 40, 5, p. 441-443 3 p.Research output: Contribution to journal › Letter › peer-review
Open Access11 Scopus citations
Press / Media
-
Icahn School Of Medicine At Mount Sinai Continues Drive To Diversify Research
5/12/22
1 item of Media coverage
Press/Media
-
Icahn School of Medicine at Mount Sinai Continues Drive to Diversify Research by Appointing New Biomedical Laureates
30/11/22 → 1/12/22
2 items of Media coverage
Press/Media
-
The curious case of the 471-day coronavirus infection
30/08/22 → 31/08/22
5 items of Media coverage
Press/Media
-
Strange case of a man who has been positive for coronavirus for 471 days
30/08/22
1 item of Media coverage
Press/Media
-
Study Shines Light on Immune Responses for Long-Lasting Protection From COVID-19
Viviana Simon & Florian Krammer,
30/05/22
2 items of Media coverage
Press/Media